Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
May 19 (Reuters) - Protagenic Therapeutics Inc PTIX.O: PROTAGENIC THERAPEUTICS INC - ENTERS SHARE EXCHANGE AGREEMENT WITH ALTEROLA AND EMC2 - SEC FILING PROTAGENIC THERAPEUTICS INC - BUYS 100% OF PHYTANIX BIO SHARES - SEC FILING Source text: [ID:n0001641172-25-011387] Further company coverage: PTIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagenic Therapeutics
See all newsBrief: Protagenic Therapeutics Inc - Alexander Arrow, CFO, To Be Terminated Effective April 30, 2026 - SEC Filing
Brief: Protagenic Therapeutics Approves Restructuring Plan on August 8- SEC Filing
Brief: Protagenic Therapeutics Granted Japanese Patent JP 7714571B
Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
Brief: Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of Common Stock Of Up To $1.2 Mln